TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 62 filers reported holding TRINITY BIOTECH PLC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $554,000 | +13.8% | 41,926 | -2.3% | 0.09% | +9.9% |
| Q2 2016 | $487,000 | -3.8% | 42,909 | -1.1% | 0.08% | -6.9% |
| Q1 2016 | $506,000 | -14.2% | 43,381 | -13.5% | 0.09% | -5.4% |
| Q4 2015 | $590,000 | +26.3% | 50,138 | +22.9% | 0.09% | +19.5% |
| Q3 2015 | $467,000 | +7.4% | 40,792 | +69.3% | 0.08% | +16.7% |
| Q2 2015 | $435,000 | -8.0% | 24,093 | -2.0% | 0.07% | 0.0% |
| Q1 2015 | $473,000 | +8.5% | 24,581 | -1.2% | 0.07% | +4.8% |
| Q4 2014 | $436,000 | -17.1% | 24,885 | -13.6% | 0.06% | -21.2% |
| Q3 2014 | $526,000 | -25.3% | 28,790 | -5.8% | 0.08% | -23.1% |
| Q2 2014 | $704,000 | -22.2% | 30,573 | -18.2% | 0.10% | -21.2% |
| Q1 2014 | $905,000 | +6.6% | 37,363 | +10.7% | 0.13% | +10.0% |
| Q4 2013 | $849,000 | +22.9% | 33,752 | +6.3% | 0.12% | +14.3% |
| Q3 2013 | $691,000 | +19.3% | 31,738 | -7.6% | 0.10% | +2.9% |
| Q2 2013 | $579,000 | – | 34,339 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 672,100 | $14,625,000 | 5.62% |
| GOLDMAN CAPITAL MANAGEMENT INC | 312,000 | $6,789,000 | 4.48% |
| Lyon Street Capital, LLC | 407,586 | $8,870,047,000 | 4.37% |
| GREAT POINT PARTNERS LLC | 189,071 | $4,114,000 | 2.85% |
| Adirondack Research & Management Inc. | 161,507 | $3,514,000 | 2.02% |
| Park West Asset Management LLC | 483,355 | $10,518,000 | 1.56% |
| Benchmark Capital Advisors | 56,954 | $1,239,000 | 0.89% |
| WOODMONT INVESTMENT COUNSEL LLC | 76,607 | $1,667,000 | 0.61% |
| SHEPHERD KAPLAN KROCHUK, LLC | 156,000 | $3,394,000 | 0.55% |
| HEARTLAND ADVISORS INC | 1,250,364 | $27,208,000 | 0.50% |